Harvard spinout eGenesis launched in 2015 in a bid to find a successful mechanism for transplanting pig organs into human beings.

EGenesis, a US-based genetics technology spinout from Harvard University, has raised $38m in a series A round backed by healthcare services provider Heritage Provider Network. The round was co-led by Biomatics Capital and Arch Venture Partners, while Alexandria Venture Investments, the venture capital arm of property developer Alexandria Real Estate Equities, also took part along…

The rest of this content is only accessible to Global Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.